SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-031227
Filing Date
2013-01-31
Accepted
2013-01-31 09:03:03
Documents
3
Period of Report
2013-01-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d476844d8k.htm 8-K 15453
2 EX-99.1 d476844dex991.htm EX-99.1 8689
3 GRAPHIC g476844ex5.jpg GRAPHIC 3612
  Complete submission text file 0001193125-13-031227.txt   30456
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 13560953
SIC: 2834 Pharmaceutical Preparations